Glioblastoma multiforme of spinal cord – Case series in a tertiary cancer centre
Background and Aim: Primary spinal cord glioblastoma multiforme (GBM) is a rare clinical condition and is often associated with a dismal prognosis. The standard treatment is maximal safe surgery followed by adjuvant radiotherapy and chemotherapy. Despite such aggressive treatments, the median survival is estimated to be around 15 months in several studies. We report three patients with primary spinal GBM who received treatment in our institute from 2012 to 2019. Among the three, one patient is on long-term follow-up with no evidence of disease, another patient succumbed to the illness and the third patient is having stable disease.
Relevance for Patients: Although primary spinal GBM is usually associated with a dismal prognosis, our case series shows a subset of patients will have a favorable outcome with the protocol treatment.
[1] Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010. Neuro Oncol 2013;15 Suppl 2:ii1-56.
[2] Caroli E, Salvati M, Ferrante L. Spinal Glioblastoma with Brain Relapse in a Child: Clinical Considerations. Spinal Cord 2005;43:565-7.
[3] Kim WH, Yoon SH, Kim CY, Kim KJ, Lee MM, Choe G, et al. Temozolomide for Malignant Primary Spinal Cord Glioma: An Experience of Six Cases and a Literature Review. J Neurooncol 2011;101:247-54.
[4] Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Long-Term Follow-up of Intramedullary Spinal Cord Tumors: A Series of 202 Cases. Neurosurgery 2005;56:972-81.
[5] Morais N, Mascarenhas L, Soares-Fernandes JP, Silva A, Magalhães Z, da Costa JA. Primary Spinal Glioblastoma: A Case Report and Review of the Literature. Oncol Lett 2013;5:992-6.
[6] Yeung YF, Wong GK, Zhu XL, Ma BB, Hk NG, Poon WS. Radiation-Induced Spinal Glioblastoma Multiforme. Acta Oncol 2006;45:87-90.
[7] Olar A, Aldape KD. Using the Molecular Classification of Glioblastoma to Inform Personalized Treatment. J Pathol 2014;232:165-77.
[8] Hegi ME, Rajakannu P, Weller M. Epidermal Growth Factor Receptor: A Re-Emerging Target in Glioblastoma. Curr Opin Neurol 2012;25:774-9.
[9] Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr., et al. TERT Promoter Mutations Occur Frequently in Gliomas and a Subset of Tumors Derived from Cells with Low Rates of Self-Renewal. Proc Natl Acad Sci USA 2013;110:6021-6.
[10] Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. N Engl J Med 2005;352:997-1003.
[11] Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, et al. Prognostic or Predictive Value of MGMT Promoter Methylation in Gliomas Depends on IDH1 Mutation. Neurology 2013;81:1515-22.
[12] Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-Hydroxyglutarate is a Competitive Inhibitor of Alpha-Ketoglutarate-Dependent Dioxygenases. Cancer Cell 2011;19:17-30.
[13] Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, et al. Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma. Cancer Cell 2010;17:510-22.
[14] Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 2005;352:987-96.
[15] Halperin EC, Brady LW, Wazer DE, Perez CA. Perez and Brady’s Principles and Practice of Radiation Oncology. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins, Wolters Kluwer Business; 2013. p. 659-94.
[16] Asano N, Kitamura K, Seo Y, Mukai K, Soga T, Hondo H, et al. Spinal Cord Glioblastoma Multiforme with Intracranial Dissemination-case report. Neurol Med Chir (Tokyo) 1990;30:489-94.
[17] Yamazaki M, Ikota T, Ohkata N, Tashiro T, Sawamura Y, Iwasaki Y, et al. A Case of Spinal Cord Glioblastoma Multiforme. No Shinkei Geka 1992;20:85-9.
[18] Marchan EM, Sekula RF, Jannetta PJ, Quigley MR. LongTerm Survival Enhanced by Cordectomy in a Patient with a Spinal Glioblastoma Multiforme and Paraplegia: Case Report. J Neurosurg 2007;7:656-9.